Видео ютуба по тегу Sglt-2 Inhibitors

How does Dapagliflozin work? Understanding SGLT2 inhibitors.
How does Dapagliflozin work? Understanding SGLT2 inhibitors.
When Should We Use SGLT2 Inhibitors?
When Should We Use SGLT2 Inhibitors?
Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists
Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists
ESC TV Conversations - SGLT2 inhibitors – wonder drugs in Heart Failure and beyond?
ESC TV Conversations - SGLT2 inhibitors – wonder drugs in Heart Failure and beyond?
Part 6 - Primary Care Insights from the KDIGO CKD Guideline: SGLT2 Inhibitors
Part 6 - Primary Care Insights from the KDIGO CKD Guideline: SGLT2 Inhibitors
SGLT2 Inhibitors in Chronic Kidney Disease
SGLT2 Inhibitors in Chronic Kidney Disease
Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?'
Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?'
SGLT2 Inhibitors Mechanism of Action
SGLT2 Inhibitors Mechanism of Action
Using SGLT2-inhibitors to treat cardiac patients with diabetes
Using SGLT2-inhibitors to treat cardiac patients with diabetes
Cardiovascular Benefit With SGLT2 Inhibition
Cardiovascular Benefit With SGLT2 Inhibition
SGLT2 Inhibitors are Associated With Reduced CV Disease in Type 2 Diabetes
SGLT2 Inhibitors are Associated With Reduced CV Disease in Type 2 Diabetes
SGLT2 Inhibitors vs GLP-1 Agonists: A Cardiologist and an Endocrinologist Weigh In
SGLT2 Inhibitors vs GLP-1 Agonists: A Cardiologist and an Endocrinologist Weigh In
SGLT2 inhibitors in heart failure: New analyses and recent updates
SGLT2 inhibitors in heart failure: New analyses and recent updates
Controlling Diabetes With SGLT-2 Inhibitors May Also Reduce Heart Failure or Kidney Disease
Controlling Diabetes With SGLT-2 Inhibitors May Also Reduce Heart Failure or Kidney Disease
SGLT2 Inhibitors: Can these drugs slow the progression of chronic kidney disease?
SGLT2 Inhibitors: Can these drugs slow the progression of chronic kidney disease?
SGLT2 Inhibitors in Patients Without Diabetes at Risk of HF
SGLT2 Inhibitors in Patients Without Diabetes at Risk of HF
A Tale of Salt and Sugar: SGLT2 Inhibitors in Cardiovascular Disease
A Tale of Salt and Sugar: SGLT2 Inhibitors in Cardiovascular Disease
Jeffrey Berger, MD: Deciding Between GLP1 Agonists or SGLT2 Inhibitors
Jeffrey Berger, MD: Deciding Between GLP1 Agonists or SGLT2 Inhibitors
Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists
Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists
How SGLT2 Inhibitors Protect The Kidney
How SGLT2 Inhibitors Protect The Kidney